Efficacies of artemether–lumefantrine, artesunate–amodiaquine, dihydroartemisinin–piperaquine, and artesunate–pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial

Authors:

Abstract
No abstract available
Funding Information
  • Foundation for the National Institutes of Health
  • United States Agency for International Development
  • President's Malaria Initiative

This publication has 26 references indexed in Scilit: